THE THROGMORTON TRUST PLC
All information is at 30 June 2013 and unaudited.
Performance at month end is calculated on a cum income basis
One Three One Three
Month Months Year Years
Net asset value* -3.4% 1.1% 29.9% 98.5%
Net asset value -3.4% 1.1% 29.9% 85.3%
Share price -3.3% 4.0% 38.4% 86.2%
Numis plus AIM (ex Inv Cos) -3.2% -0.7% 23.9% 49.7%
Sources: BlackRock and Datastream
* Prior to dilution arising on conversion of subscription shares.
At month end
Net asset value capital only: 274.82p
Net asset value incl. income: 277.74p
Share price: 235.50p
Discount to cum income NAV 15.2%
Net yield: 1.4%*
Total assets: £203.1**
Net market exposure as
a % of net asset value^: 104.9%
Ordinary shares in issue: 73,130,326***
*Calculated using prior year interim and final dividends paid.
**Includes current year revenue and excludes the gross exposure through
contracts for difference.
***Excluding 7,400,000 shares held in treasury.
^Long positions less short positions as a percentage of net asset value.
Sector Weightings % of total assets
Industrials 24.5
Consumer Services 21.3
Financials 19.2
Consumer Goods 9.6
Technology 7.9
Basic Materials 6.7
Health Care 6.5
Oil & Gas 4.0
Telecommunications 1.6
Net current liabilities -1.3
-----
Total 100.0
=====
Market Exposure (Quarterly)
31.08.12 30.11.12 28.02.13 31.05.13
Long 116.1% 115.6% 118.0% 117.3%
Short 12.3% 10.8% 10.5% 10.2%
Gross exposure 128.4% 126.4% 128.5% 127.5%
Net exposure 103.8% 104.8% 107.5% 107.1%
Ten Largest Equity Investments
Company % of total assets
Bellway 2.7
Howden Joinery Group 2.6
Senior 2.4
Workspace 2.2
ITE 2.1
Dunelm Group 2.0
Booker Group 2.0
Victrex 1.8
Ashtead 1.8
Restaurant 1.8
Commenting on the markets, Mike Prentis and Richard Plackett, representing the
Investment Manager noted:
During June the Company's NAV per share fell by 3.4% on a cum income basis. The
benchmark index fell by 3.2% whilst the FTSE 100 Index fell by 5.5%; both on a
cum income basis. Markets were nervous following comments by the Chairman of
the US Federal Reserve indicating that bond purchases would be reduced in due
course. Markets were also unnerved by weaker data from China, falls in emerging
market currencies and demonstrations in Turkey, Brazil and Egypt.
The relative contribution from the long only portfolio stock selection was
positive. However, contribution from sector allocation was slightly negative.
The CFD portfolio continues to be net long and, in a falling market, losses on
the longs exceeded gains on the shorts resulting in a net loss for the month.
The main positive contribution from stock selection came again from Xaar, which
is held in both the long only portfolio and the CFD portfolio. Xaar produced
another strong trading update which led to further significant earnings
upgrades.
On the negative side, the largest contributor to stock selection was Oxford
Instruments which announced full year results in line with expectations but
indicated that the new financial year had got off to a slow start. The company
sells instruments into research labs and some of these have been affected by
recent US Government spending cuts. We continue to see Oxford Instruments as a
core holding with strong management, products and finances and believe it will
be a bigger company in the medium term.
During the month we took profits in some non-core holdings exposed to emerging
markets given concerns about growth. We decided to add to our UK property
exposure where we see reasonable value after the pullback over the last six
weeks. We added a holding in Quintain Estates and bought back into Shaftesbury,
both companies giving us further exposure to the London property market.
12 July 2013
ENDS
Latest information is available by typing www.blackrock.co.uk/thrg on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.